Product Liability Forum | Compensation Schemes for COVID-19 vaccines: UK, comparative and international perspectives.

Event Details

This seminar will focus on the topic of compensation for potential adverse events caused by CV-19 vaccines. There have been a series of developments concerning compensation schemes. A paper was recently published by an interdisciplinary group of academics drawing upon historical, ethical, and legal perspectives to argue that a bespoke compensation scheme needs to be launched "without delay" and would play a significant role in ensuring the acceptability of COVID-19 vaccines to the general public. The paper can be downloaded here.

At an international level, a similar proposal on compensation schemes has been made by the COVAX vaccine facility, co-led by WHO and GAVI, in favour of a public-private co-financed no-fault scheme to compensate those in low-income countries who suffer any side-effects from COVID-19 vaccines. For further details, see here.

Chair

Prof. Duncan Fairgrieve, BIICL

Panelists

• Dr Samantha Vanderslottt, Oxford Vaccines Group, University of Oxford
• Dr Claas Kirchhelle, University of Oxford
• Prof. Geraint Howells, University of Manchester
• Prof. Søren Holm, Professor of Bioethics, University of Manchester
• Adam Heppinstall, Henderson Chambers
• Prof. Samuel Dahan, Queen's University Canada / Cornell Law School
• Anthony Brown, GAVI, The Vaccine Alliance;
  

Event convened by Prof. Duncan Fairgrieve, Senior Research Fellow in Comparative Law & Director, Product Liability Forum at the British Institute of International and Comparative Law (BIICL).

Pricing and Registration

This event is for members of the Product Liability Forum only. Anyone wishing to attend should contact the Events team.